Related Experiment Video
Updated: Aug 11, 2026

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients
Published on: July 12, 2024
Use of nonprescription medications by patients with congestive heart failure
M L Ackman1, J B Campbell, K A Buzak
1Regional Pharmacy Service, Capital Health, Edmonton, Alberta, Canada.
Insights
Patients with congestive heart failure (CHF) use nonprescription therapies similarly to those without heart conditions. CHF patients show caution with potentially harmful cough and cold products.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Nonprescription therapies are widely used, but their utilization patterns in patients with congestive heart failure (CHF) are not well-defined.
- Understanding the use of over-the-counter medications in CHF patients is crucial for managing potential drug interactions and adverse effects.
Purpose of the Study:
- To determine the usage patterns of nonprescription therapies among patients diagnosed with congestive heart failure (CHF).
- To compare the nonprescription therapy utilization of CHF patients with an age- and gender-matched control group without heart conditions.
Main Methods:
- A survey questionnaire was administered to patients attending an ambulatory CHF clinic and to a control group.
- Participants completed the survey at home, detailing nonprescription therapies used at least once weekly.
- The study included 180 CHF patients and 133 control subjects, matched for age and gender.
Main Results:
- The most common nonprescription categories for both groups were vitamins/minerals, pain relievers, herbal products, antacids, and laxatives, with no significant differences.
- CHF patients used significantly fewer cough and cold products (9% vs. 17%) and oral decongestants (0.6% vs. 5%) compared to controls.
- Conversely, CHF patients reported higher use of nutritional supplements (17% vs. 4%) than the control group.
Conclusions:
- Overall nonprescription therapy use in CHF patients is comparable to the general population without heart conditions.
- CHF patients exhibit appropriate caution by avoiding potentially harmful cough and cold products.
- Observed differences in specific nonprescription product use highlight potential patient awareness regarding medication safety in heart failure.
Objective:
To define the utilization pattern of nonprescription therapies in patients with congestive heart failure (CHF) and to compare this pattern with that of an age- and gender-matched control group without any self-reported heart conditions.
Design:
Survey questionnaire completed by participants at home.
Setting:
Ambulatory CHF clinic in a tertiary care hospital.
Subjects:
Patients attending the clinic between July 1995 and May 1996 who agreed to participate. Control subjects were age- and gender-matched participants identified and approached by participating patients.
Outcome Measures:
Nonprescription therapies used at least once weekly.
Results:
Completed questionnaires were received from 180 (75%) of the 239 patients who agreed to participate and from 133 controls. Mean age of responding patients was 69 years (63% men). Controls were younger, with a mean age of 64 years (63% men). The most commonly used nonprescription medication categories for both patients and controls, with no significant intergroup differences, were vitamins and minerals (59% patients, 50% controls), pain relievers (48% and 43%, respectively), herbal or health food products (38% and 38%), antacids (26% and 28%), and laxatives (24% and 21%). Significantly fewer patients than controls used cough and cold products (9% vs. 17%; p < 0.05), specifically oral decongestants (0.6% vs. 5%; p < 0.01), and more patients than controls used nutritional supplements (17% vs. 4%; p < 0.01).
Conclusions:
Overall, use of nonprescription therapies by our CHF clinic patients is similar to that of an age- and gender-matched population without a self-reported heart condition. The differences in medication use observed between patients and controls included cough and cold products that might be harmful. This likely reflects appropriate caution with which CHF patients approach nonprescription therapies.
Related Concept Videos
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: β-Blockers
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions